
Real Questions
4
Pharma
-
Pharma: Time to provide education and pricing to the clinicians where they need it most
-
Why are you still struggling with clinical documentation shortfalls for new drugs?
-
Why are you still struggling with medical necessity documentation from clinicians?
-
Why is retail pharmacy still struggling with lack of prior authorization?
-
Why is retail pharmacy still struggling with plan step protocol formularies?
-
Why are you still struggling with clinicians obtaining prior auth needed for brand drugs?
-
Why are you still struggling with clinicians obtaining prior auth for step protocol drugs?
-
Why are you still not using tools for clinicians for compliance with indications for use.
-
Why are you still not using digital tools for clinicians to understand exclusion criteria?
-
Why are you still not using tools for clinicians to understand diagnosis specific use case?
-
Why are you still not utilizing PBMs that do not automate the prior auth process?
-
Why are you still not utilizing PBMs that provide cost transparency as in Florida’s EO?
-
Why are you still allowing abandonment of care due to lack of prior auth?
-
Why are you still providing only tracking drug prior auth & not using point of care tools?
